Who is sponsoring NCT03865576?

NCT03865576 is sponsored by Boston Neurosciences.

What drugs are being tested in NCT03865576?

Interventions in NCT03865576: Non-invasive ICP measurement.

What condition does NCT03865576 study?

NCT03865576 studies Intracranial Hypertension, Abnormality of Intracranial Pressure.

Is NCT03865576 still recruiting?

NCT03865576 is currently status unknown. Last updated 7 March 2019.

Last reviewed 2019-03-07 · How we verify

NCT03865576

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device

Status unknown Last updated 7 March 2019

What this trial tests

trial testing Non-invasive ICP measurement in Intracranial Hypertension in 80 participants. Status unknown.

Timeline

1 March 2019

Primary endpoint
31 October 2019

31 October 2019

Quick facts

Lead sponsor	Boston Neurosciences
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	80
Start date	1 March 2019
Primary completion	31 October 2019
Estimated completion	31 October 2019
Sites	4 locations across United States

Drugs / interventions tested

Non-invasive ICP measurement

Conditions studied

Intracranial Hypertension — all drugs for Intracranial Hypertension →
Abnormality of Intracranial Pressure — all drugs for Abnormality of Intracranial Pressure →

Sponsor

Boston Neurosciences

Who can join

Adults 18 to 80, any sex, with Intracranial Hypertension or Abnormality of Intracranial Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

For purposes of validation, this study compares intracranial pressure measurements obtained with a novel self-calibrating, non-invasive, intracranial pressure measuring (ICP) device, with the values obtained from (a) patients in an intensive care unit (ICU) whose meet standard clinical indications for ICP measurement and whose ICP is measured using gold-standard implanted intracranial instrumentation and in (b) ambulatory subjects who meet clinical indications for lumbar puncture.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Intracranial Hypertension

Currently open trials in the same condition.

NCT07332234 — Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral Pathologies · recruiting
NCT06634069 — Study SOLACE SEPSIS · Phase 2 · recruiting
NCT05889650 — External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial · NA · recruiting
NCT04459806 — Intracranial PrEssure Time dOse (ImPETO) · recruiting
NCT05340062 — Non Invasive Measurement With Trans Cranial Doppler Versus Invasive Measurement in Pediatric Age · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03865576 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Boston Neurosciences
Last refreshed: 7 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03865576.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing